Notable 52-Week Highs and Lows 8/17: (URBN) (AMKR) (PLCE) High; (CSIQ) (VRS) (EBS) Low

August 17, 2016 3:25 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

52-Week High:
  • Urban Outfitters (Nasdaq: URBN) $37.16. Urban Outfitters reported Q2 EPS of $0.66, which was $0.10 better than the analyst estimate of $0.56. Revenue for the quarter came in at $890.6 million versus the consensus estimate of $886.84 million.

  • Amkor Technology (Nasdaq: AMKR) $9.54. Amkor Technology shares are higher Wednesday over speculation that Nantong Fujitsu Microelectronics might be interested in acquiring the company.

  • Children's Place (Nasdaq: PLCE) $90.00. Children's Place reported Q2 EPS of ($0.33), versus the analyst estimate of ($0.23). Revenue for the quarter came in at $371.4 million versus the consensus estimate of $367.51 million. Comps rose 2.4%. Children's Place sees FY2016 EPS of $4.60 - $4.70, versus prior guidance of $4.17 - $4.27 and the consensus of $4.26.
52-Week Low:
  • Canadian Solar Inc. (Nasdaq: CSIQ), $12.12. Canadian Solar shares sinking lower ahead of the company's Q2 report on Thursday. The stock was down as much as 7.3 percent.

  • Verso Corporation (NYSE: VRS) $7.44. Verso Corporation continuing lower from Tuesday after it reported Q2 results. Net sales for the second quarter of 2016 were 19% lower than the second quarter of 2015. Net loss was $33 million, versus $60 million posted in Q215.

  • Emergent BioSolutions Inc. (NYSE: EBS) $26.52. Emergent BioSolutions also seeing a little additional downside early today following a drop on Tuesday. Yesterday, the company announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for the manufacture of BioThrax® (Anthrax Vaccine Adsorbed) in Building 55, the company’s large-scale manufacturing facility located in its 12.5-acre campus in Lansing, Michigan.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Add Your Comment